The coronavirus pandemic which has already killed more than 5 million people around the world is far from over, and the next outbreak could be even worse, says a vaccine inventor.

Next outbreak could be worse, warns Oxford vaccine maker

World Health Organization (WHO) has urged western countries to not start the booster programme yet as several poorer countries have been unable to vaccinate even the vulnerable population.

Covid booster shot not needed for everyone, Oxford vaccine creator says

Amid the unprecedented Covid crisis in India, the United States government will redirect from its own supplies 20 million doses of Astra Zeneca vaccines. The timeline will be conveyed by Washington to New Delhi soon.

India Covid crisis: US to redirect 20 million doses of AstraZeneca vaccines, send raw material to manufacture 500,000 doses

One shot of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine reduces coronavirus infections by nearly two-thirds and protects older and more vulnerable people as much as younger, healthy individuals, a study has found.

One dose of Pfizer or Oxford jab reduces coronavirus infection rate by 65%, says study

The EU's drug watchdog on Friday said that Oxford-AstraZeneca's coronavirus vaccine's benefits increase with age. "It showed that the benefits of vaccination increase with increasing age and infection rates," the European Medicines Agency (EMA) in a statement said, as quoted by news agency AFP.

Benefits of Oxford-AstraZeneca vaccine increase with age: EU's watchdog

Covid-19 leads to a risk of rare blood clots that’s higher than that of current vaccines, said scientists of the University of Oxford amid concerns that the jabs may be to blame for the potentially deadly condition.

Rare blood clot risk higher from coronavirus than vaccine, says UK study

Canadian health authority on Tuesday reported the nation's first blood clotting case related to the Oxford-AstraZeneca jab. Health Canada said a Quebec woman who had received the coronavirus vaccine prepared by the Serum Institute of India was Canada's first case of blood clotting with low platelets.

Canada reports first blood clot case linked to AstraZeneca vaccine

Denmark on Tuesday banned the use of Oxford-AstraZeneca coronavirus vaccine, becoming the first European nation to take such action over rare but serious suspected health risks.

Denmark becomes first European nation to stop using AstraZeneca vaccine

EU health regulator on Thursday said that 'no evidence' was found of any direct links between either AstraZeneca or Pfizer Covid vaccine and blood clots. "The committee has come to a clear scientific conclusion: this is a safe and effective vaccine," European Medicines Agency (EMA) chief Emer Cooke told a press conference after an investigation.

EU, UK regulator shrug off AstraZeneca vaccine concerns

To quell fears around the Oxford-AstraZeneca coronavirus vaccine, UK PM Boris Johnson on Wednesday said that he will take the jab. "I finally got news and I've got to have my own jab, very shortly, I'm pleased to discover," the British PM told lawmakers.

UK's Boris Johnson to get AstraZeneca vaccine as he dismisses safety fears

After several Nordic nations suspended the use of Oxford-AstraZeneca's coronavirus vaccine, the European Union's drug regulator advised European countries to keep using the jabs during a probe of blood clots cases.

Oxford-AstraZeneca Covid-19 vaccine can be used until probe results: EU regulator

The Italian government has blocked the Australia-bound shipment of Oxford-AstraZeneca coronavirus vaccine's 250,000 doses. Italy blamed the export ban on the doses produced in an Italian facility on the shortage of vaccines in Europe and a better situation in Australia when it comes to dealing with Covid-19.

Italy blocks export of Oxford-AstraZeneca vaccine shipment to Australia

Pakistan is gearing up to begin an inoculation drive. The county has secured 17 million doses of Oxford university and Astrazeneca's COVID-19 vaccine.

Pakistan secures 17 million doses of Astrazeneca's vaccine

AstraZeneca and Oxford University had filed a formal bid for authorisation for their coronavirus vaccine, the European Medicines Agency said.

Europe ramps up vaccination drive amid surge in Covid-19 cases

The Oxford Vaccine is one step away from a rollout in India. Sources tell WION that an expert panel has cleared the shot. Palki Sharma tells you more.

Gravitas: Oxford Vaccine, One step away from approval in India

There are still important questions about what dose would be best, as well as the age group it will protect the most.

'Oxford-AstraZeneca vaccine safe and effective', claims Lancet report

UK is planning to a 'mix & match' trial of Oxford & Pfizer vaccines. The pilot trial has been scheduled for January 2021.

UK to begin trial to 'mix & match' COVID-19 vaccines from Jan 2021

The Hyderabad-based pharmaceutical firm Bharat Biotech applied to the Drugs Controller General of India (DCGI) on Monday for granting emergency use authorisation for its COVID-19 vaccine Covaxin, becoming the third company after American pharma giant Pfizer and Pune-based Serum Institute of India (SII) to seek emergency use authorisation for its Covid-19 vaccine candidate.

Bharat Biotech seeks emergency use authorisation for Indian Covid-19 vaccine; expert panel to review

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine 'Covishield' in the country,

News Alert: Serum institute seeks emergency use nod for 'Covishield' vaccine in India

The Serum Institute of India (SII) applied to the Drugs Controller General of India (DCGI) on Sunday for granting emergency use authorisation for the Oxford-AstraZeneca coronavirus vaccine.

Serum Institute of India applies for emergency use authorisation for Oxford vaccine

An Oxford vaccine trial volunteer in India claims he suffered a 'virtual neurological breakdown' after the shot. The Serum Institute has called the charge 'malicious' and threatened to file a 100 Crore defamation case.

Gravitas: Oxford Vaccine: Serum Institute seeks 100 crores from vaccine volunteer

Prime Minister Narendra Modi will visit the Pune-based Serum Institute of India on November 28, a senior official said on Thursday. The Serum Institute of India, the world's largest manufacturer of vaccines by volume, has partnered with global pharma giant AstraZeneca and Oxford University for the COVID-19 vaccine.

Coronavirus vaccine tracker: PM Modi to visit Serum Institute of India on November 28

The makers of the Oxford vaccine want to sell their shot at cost price to developing countries. How are other vaccine makers planning to price their vaccines? WION's Molly Gambhir has the details.

Gravitas: Will the Oxford shot be the cheapest available vaccine?

The potential vaccine against the novel coronavirus maybe around 90 percent effective, the company said citing interim analysis of results from late-stage clinical trials.

Oxford, AstraZeneca say their candidate prevents average 70% people from getting COVID

oxford-vaccine

Oxford Vaccine, News on Oxford Vaccine, stories on Oxford Vaccine, articles on Oxford Vaccine, Oxford Vaccine stories at Wion, Oxford Vaccine news, Oxford Vaccine latest news

oxford vaccine